Reglagene Holding, Inc. was selected as an Innovation Excellence winner of the Freedom from Cancer Startup Challenge (FCSC). The FCSC is a nationwide contest dedicated to startups that better prevent, diagnose, treat, and cure cancers.
Winners of the Cancer Startup Challenge were selected by a multi-disciplinary judging panel, comprised of industry experts, potential investors, philanthropists, and more. The winning startups were selected based on their 10-page business plans, financial models, 20-minute “live pitches”, and engagement in CAI’s White House-recognized accelerator program. Reglagene, a startup stemming from research at the The University of Arizona, placed in the upper tier of the Cancer Startup Challenge.